SCHEMBL6038373

SCHEMBL6038373

COc1ccc(NS(=O)(=O)c2ccc(CCCNC(=O)c3cc4ccccc4o3)cc2)cc1OC

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.64
OPRM1 P35372 1/20 0.59
TMEM97 Q5BJF2 1/20 0.59
SIGMAR1 Q99720 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.58
RAB9A P51151 3/20 0.57
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
GAA P10253 2/20 0.49
ALDH1A1 P00352 2/20 0.49
KDM4E B2RXH2 1/20 0.49
TP53 P04637 1/20 0.49
MAPT P10636 1/20 0.49
HPGD P15428 1/20 0.49
TSHR P16473 1/20 0.49
HKDC1 Q2TB90 1/20 0.49
HSD17B10 Q99714 1/20 0.49
HTR1A P08908 1/20 0.48
DRD2 P14416 1/20 0.48
DRD1 P21728 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10073043 0.79 NAMPT (1.00) NAMPTOPRM1TMEM97SIGMAR1L3MBTL1
SCHEMBL6038015 0.74 MAPT (0.49) NAMPTL3MBTL1KMT2AALDH1A1MAPT
SCHEMBL6038182 0.73 LMNA (0.68) RAB9AMEN1KMT2AALDH1A1KDM4E
SCHEMBL6037941 0.73 ALDH1A1 (0.49) NAMPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL6038220 0.73 LMNA (0.48) NAMPTMEN1KMT2AGAAALDH1A1
SCHEMBL5278266 0.73 LMNA (0.48) L3MBTL1GAAALDH1A1LMNASMN1; SMN2
SCHEMBL8261335 0.73 LMNA (0.48) NAMPTRAB9AMEN1KMT2AGAA
SCHEMBL6038095 0.72 LMNA (0.64) NAMPTL3MBTL1MEN1KMT2AGAA
SCHEMBL416296 0.71 HDAC1 (0.64) NAMPTOPRM1TMEM97SIGMAR1RAB9A
SCHEMBL6038074 0.71 PKM (0.44) NAMPTRAB9AGAAALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264415-A1 Inhibitors of histone deacetylase HDAC1, HDAC3, HDAC11 NAMPT 1262/4885OPRM1 4082/4885TMEM97 4336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.